M3-JIA: Making Mindfulness Matter for Children With JIA

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age4-12
SponsorLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

About this trial

The investigator will evaluate the efficacy of M3©, an intervention for patients with JIA and their caregivers. Children with Juvenile arthritis and their parents will attend an 8 week online program called Making Mindfulness Matter (M3). This is a facilitator-led program that integrates knowledge and skills related to mindfulness, social-emotional learning, neuroscience, and positive psychology to promote coping and resiliency for children and families in context of the challenges of pediatric chronic disease. The child program is designed for children 4-12 years of age, with each lesson including a variety of concrete ways to teach children skills based on their age/developmental level.

Eligibility criteria

Qualifiers

Children aged 4 to 12 years diagnosed with JIA

Children have reasonable comprehension of spoken language and can follow simple instructions

Children with JIA and their caregivers are willing to attend intervention sessions and have access to technology and internet to attend the online sessions.

Children with JIA and their caregivers have an adequate understanding of English

Disqualifiers

Other major co-morbid disorders (e.g. Crohn's disease, diabetes, renal failure).

Concurrent enrollment in other intervention trials or practicing any complementary health interventions such as yoga, meditation, or daily mindfulness practice.

Trial design

Treatments tested in this trial

  • M3 Intervention group
  • M3 Waitlist Group

Treatment groups

74 Participants
are divided into 2 treatment groups